RT Journal Article
SR Electronic
T1 A deep convolutional neural network-based algorithm for muscle biopsy diagnosis outperforms human specialists
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.15.20248231
DO 10.1101/2020.12.15.20248231
A1 Kabeya, Yoshinori
A1 Okubo, Mariko
A1 Yonezawa, Sho
A1 Nakano, Hiroki
A1 Inoue, Michio
A1 Ogasawara, Masashi
A1 Saito, Yoshihiko
A1 Tanboon, Jantima
A1 Indrawati, Luh Ari
A1 Kumutpongpanich, Theerawat
A1 Chen, Yen-Lin
A1 Yoshioka, Wakako
A1 Hayashi, Shinichiro
A1 Iwamori, Toshiya
A1 Takeuchi, Yusuke
A1 Tokumasu, Reitaro
A1 Takano, Atsushi
A1 Matsuda, Fumihiko
A1 Nishino, Ichizo
YR 2020
UL http://medrxiv.org/content/early/2020/12/16/2020.12.15.20248231.abstract
AB Histopathologic evaluation is essential for categorizing and studying neuromuscular disorders. However, experienced specialists and pathologists are limited, especially in underserved areas. Although new technologies, such as artificial intelligence, are expected to improve medical reach, their use in rare diseases is challenging because of the limited availability of training datasets. To address this knowledge gap, we developed an algorithm based on deep convolutional neural networks that used data from microscopic images of hematoxylin-and-eosin-stained pathology slides. Our algorithm differentiated idiopathic inflammatory myopathies (mostly treatable) from hereditary muscle diseases (mostly non-treatable) and achieved better sensitivity and specificity than real physicians’ diagnoses. Furthermore, it successfully and accurately classified four subtypes of the abovementioned muscular conditions. These results suggest that our algorithm can be safely used in a clinical setting. We established the similarity between the algorithm’s and physicians’ predictions using visualization technology, and clarified the validity of the predictions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the Japan Agency for Medical Research and Development (AMED) under grant number JP18ek0109348.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical Committee at National Center of Neurology and PsychiatryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDetailed data will be available upon request.